Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis

Autologous antigen-specific therapies based on tolerogenic dendritic cells (tolDC) offer the possibility to treat autoimmune diseases by restoring homeostasis and targeting specifically autoreactive responses. Here, we explore the hypothesis that systemic inflammation occurring in autoimmune disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Quirant-Sánchez, Bibiana, Mansilla, María José, Navarro-Barriuso, Juan, Presas-Rodríguez, Silvia, Teniente-Serra, Aina, Fondelli, Federico, Ramo-Tello, Cristina, Martínez-Cáceres, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698295/
https://www.ncbi.nlm.nih.gov/pubmed/34944573
http://dx.doi.org/10.3390/biomedicines9121758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698295/
https://www.ncbi.nlm.nih.gov/pubmed/34944573
http://dx.doi.org/10.3390/biomedicines9121758

Ejemplares similares